(Reuters) – India’s Cipla Ltd has received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by Moderna Inc for restricted emergency use, CNBC-TV18 reported on Tuesday.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur)
